🇺🇸 Provera (medroxyprogesterone) in United States

FDA authorised Provera (medroxyprogesterone) on 18 June 1959

Marketing authorisation

FDA — authorised 18 June 1959

  • Application: NDA011839
  • Marketing authorisation holder: PFIZER
  • Local brand name: PROVERA
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is Provera (medroxyprogesterone) approved in United States?

Yes. FDA authorised it on 18 June 1959.

Who is the marketing authorisation holder for Provera (medroxyprogesterone) in United States?

PFIZER holds the US marketing authorisation.